You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 9,820,959


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,820,959 protect, and when does it expire?

Patent 9,820,959 protects PICATO and is included in one NDA.

This patent has thirty-two patent family members in twenty-one countries.

Summary for Patent: 9,820,959
Patent landscape, scope, and claims:
Title:Therapeutic compositions
Abstract: Ingenol angelate is a potent anticancer agent, and can be stabilized by dissolving it in an aprotic solvent in the presence of an acidic buffer.
Inventor(s): Brown; Marc Barry (Watford, GB), Crothers; Michael Edward Donald (Hillsborough, GB), Nazir; Tahir (Middlesex, GB)
Assignee: LEO Laboratories Limited (Dublin, IE)
Application Number:15/163,390
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,820,959
Patent Claim Types:
see list of patent claims
Use; Formulation;

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,820,959

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Leo Labs PICATO ingenol mebutate GEL;TOPICAL 202833-001 Jan 23, 2012 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y USE OF INGENOL MEBUTATE TO TREAT ACTINIC KERATOSIS ⤷  Subscribe
Leo Labs PICATO ingenol mebutate GEL;TOPICAL 202833-002 Jan 23, 2012 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y USE OF INGENOL MEBUTATE TO TREAT ACTINIC KERATOSIS ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,820,959

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0525680.5Dec 16, 2005

International Family Members for US Patent 9,820,959

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1988877 ⤷  Subscribe C300682 Netherlands ⤷  Subscribe
European Patent Office 1988877 ⤷  Subscribe PA2014030 Lithuania ⤷  Subscribe
European Patent Office 1988877 ⤷  Subscribe CA 2014 00042 Denmark ⤷  Subscribe
European Patent Office 1988877 ⤷  Subscribe C20140025 00111 Estonia ⤷  Subscribe
European Patent Office 1988877 ⤷  Subscribe C01988877/01 Switzerland ⤷  Subscribe
European Patent Office 1988877 ⤷  Subscribe 14C0058 France ⤷  Subscribe
European Patent Office 1988877 ⤷  Subscribe 300682 Netherlands ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.